PRODUCT
首頁
產品資訊
PRODUCT
首頁
產品資訊
產品特點
- 簡介：樣本延遲配對（Delayed Matching to Sample，DMS）針對非語言表達的圖案，評估其視覺配對能力及短期視覺再認記憶。此測驗主要對內側額葉區域損傷患者的前額葉訊號輸入較為敏感。
- 施測時間：大約 7 分鐘，視實際情況而定。
- 作業：螢幕上顯示一個複雜的抽象非語言圖案（即樣本圖案），經過短暫的延遲之後，會出現 4 個相似的圖案。受測者需選擇與樣本圖案完全相同的圖案。
- 測驗結果：包括延遲時間（受測者的反應速度）、選擇正確圖案的次數、正確或錯誤反應後下個試驗錯誤率的統計分析…等。
相關型錄/資訊
產品規格
主要參考文獻
Cantab Depression Battery
- Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2013 Oct 29:1-12. [Epub ahead of print]
- Roiser JP, Sahakian BJ. Hot and cold cognition in depression. CNS Spectr. 2013 Jun;18(3):139-49.
- Egerházi A, Balla P, Ritzl A, Varga Z, Frecska E, Berecz R. Automated Neuropsychological Test Battery in depression -- preliminary data. Neuropsychopharmacol Hung. 2013 Mar;15(1):5-11.
- Greer TL, Sunderajan P, Grannemann BD, Kurian BT, Trivedi MH. Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction? Depress Res Treat. 2014;2014:627863.
- van Tol MJ, van der Wee NJ, Demenescu LR, Nielen MM, Aleman A, Renken R, van Buchem MA, Zitman FG, Veltman DJ. Functional MRI correlates of visuospatial planning in out-patient depression and anxiety. Acta Psychiatr Scand. 2011 Oct;124(4):273-84.
- Papakostas GI. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice. J Clin Psychiatry. 2014 Jan;75(1):8-14.
Cantab Alzheimer’s (Dementia) Battery
- Fowler KS, Saling MM, Conway EL, Semple JM, Louis WJ. Paired associate performance in the early detection of DAT. Journal of the International Neuropsychological Society : JINS. 2002;8(1):58-71.
- Egerhazi A, Berecz R, Bartok E, Degrell I. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer’s disease. Progress in neuro-psychopharmacology & biological psychiatry. 2007;31(3):746-51. Epub 2007/02/10.
- Blackwell AD, Sahakian BJ, Vesey R, Semple JM, Robbins TW, Hodges JR. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17(1-2):42-8. Epub 2003 Oct 13.
- Greig NH, Sambamurti K, Yu QS, Brossi A, Bruinsma GB, Lahiri DK. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer’s disease. Curr Alzheimer Res. 2005;2(3):281-90.
- Atack JR. Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA. Pharmacology & therapeutics. 2010;125(1):11-26. Epub 2009/09/23.
應用領域
可應用於：
產品相關影片
樣本延遲配對測驗（Delayed Matching to Sample）